Antibody-drug conjugate–associated pneumonitis (AAP) across novel first-in-human phase I trials: A pooled single-center analysis.
524 Background: Antibody-drug conjugates (ADCs) are increasingly used in cancer care; toxicities like Antibody-Drug Conjugate Associated Pneumonitis (AAP) have emerged as clinically significant & fatal adverse events. Data characterizing AAP across phase 1 trials is limited. Methods: We retrospectively collec...